Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci Res ; 85(5): 1119-25, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17304568

ABSTRACT

The iron chelator desferrioxamine (DFO) induces accumulation of the hypoxia-inducible factor (HIF-1), a transcription factor that up-regulates genes involved in adaptative responses to hypoxia. This property makes DFO a potential neuroprotector against hypoxic stress. We investigated in rats the effects of DFO on the ventilatory response to mild hypoxic tests and the expression of tyrosine hydroxylase (TH), a target gene of HIF-1. Two protocols were used, the first with repeated injections of 50 mg/kg DFO every 2 days during a 2-week period. This was aimed at define the time course of the ventilatory responses to a hypoxic test. In the second protocol, rats were given a single injection of 300 mg/kg DFO. Every day over 4 days, the hypoxic ventilatory response was recorded before the animal was sacrificed, and Western blot analysis of TH in the dorsal brainstem cardiorespiratory area was performed. DFO produced a delayed increase in the hypoxic ventilatory response, which appeared in the same time window as TH up-regulation (2-3 days after the bolus injection of DFO). This delay suggests a genic effect of the drug that improves the ventilatory response to hypoxia.


Subject(s)
Deferoxamine/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Hypoxia/drug therapy , Respiration/drug effects , Respiratory Center/drug effects , Tyrosine 3-Monooxygenase/genetics , Animals , Catecholamines/biosynthesis , Deferoxamine/therapeutic use , Gene Expression Regulation, Enzymologic/physiology , Hypoxia/enzymology , Hypoxia/physiopathology , Hypoxia-Inducible Factor 1/metabolism , Male , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Respiration/genetics , Respiratory Center/enzymology , Siderophores/pharmacology , Siderophores/therapeutic use , Solitary Nucleus/drug effects , Solitary Nucleus/enzymology , Treatment Outcome , Up-Regulation/drug effects , Up-Regulation/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...